Imperva Inc (IMPV) Shares Bought by Alpine Associates Management Inc.
Alpine Associates Management Inc. lifted its stake in Imperva Inc (NASDAQ:IMPV) by 7.7% during the fourth quarter, Holdings Channel reports. The firm owned 355,600 shares of the software maker’s stock after purchasing an additional 25,400 shares during the period. Alpine Associates Management Inc.’s holdings in Imperva were worth $14,117,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Sei Investments Co. grew its holdings in shares of Imperva by 196,449.0% in the fourth quarter. Sei Investments Co. now owns 96,309 shares of the software maker’s stock worth $3,824,000 after purchasing an additional 96,260 shares during the last quarter. Renaissance Group LLC bought a new position in shares of Imperva in the fourth quarter worth about $341,000. Teacher Retirement System of Texas bought a new position in shares of Imperva in the fourth quarter worth about $394,000. Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of Imperva by 181.5% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 41,100 shares of the software maker’s stock worth $1,632,000 after purchasing an additional 26,500 shares during the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Imperva by 7.2% in the fourth quarter. American Century Companies Inc. now owns 168,702 shares of the software maker’s stock worth $6,697,000 after purchasing an additional 11,283 shares during the last quarter. Hedge funds and other institutional investors own 93.61% of the company’s stock.
A number of research firms have recently commented on IMPV. BidaskClub upgraded shares of Imperva from a “hold” rating to a “buy” rating in a report on Wednesday, February 7th. Imperial Capital upped their price objective on shares of Imperva from $50.00 to $55.00 and gave the stock an “outperform” rating in a research note on Friday, February 9th. Piper Jaffray Companies raised shares of Imperva from a “neutral” rating to an “overweight” rating and set a $52.00 price objective for the company in a research note on Friday, February 9th. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the stock a “buy” rating in a research note on Friday, February 9th. Finally, Morgan Stanley upped their price objective on shares of Imperva from $37.00 to $39.00 and gave the stock an “underweight” rating in a research note on Friday, February 9th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and eleven have assigned a buy rating to the company. Imperva presently has an average rating of “Hold” and a consensus price target of $52.93.
Imperva (NASDAQ:IMPV) last released its quarterly earnings results on Thursday, February 8th. The software maker reported $0.40 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.27 by $0.13. The business had revenue of $91.10 million during the quarter, compared to analyst estimates of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. The company’s quarterly revenue was up 16.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.32 earnings per share. analysts anticipate that Imperva Inc will post -0.82 EPS for the current fiscal year.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NASDAQ:IMPV).
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.